EPHB6 and prostate carcinoma: Compared with corresponding normal tissue within the same patient, prostate cancer cells showed a significantly decreased expression level of EphB6 in 26 cases and retained a similar expression level in the remaining cases (Wilcoxon signed rank test, P<0.0001).